click below
click below
Normal Size Small Size show me how
Naplex
PAH-clinical pearl
| Question | Answer |
|---|---|
| Epoprostenol administration | Epoprostenol must be protected from light before reconstitution and during the infusion. |
| Drugs can cause pulmonary fibrosis | - Dronedarone (Multaq) - Amiodarone - Bleomycin |
| Flolan vs Veletri | - Epoprostenol - Flolan: continuous IV infusion (hospital or home). After reconstitution, Flolan solutions need to be kept cool with ice packs or other cooling packs. - Veletri: more stability, room temperature |
| Meds causes PAH | - SSRI during pregnancy (Fenfluramine -brand Fintepla) - Stimulants (methamphetamines, amphetamine) - Weight loss: phentamine |
| TRUE or FALSE: NSAIDs should be avoid in PAH | TRUE, NSAIDs increase sodium and water retention |
| Routine vaccine for PAH | - Influenza - Pneumonia |
| side effects of epoprostenol | Vasodilation reactions (hypotension, flushing, headache, nausea, vomiting) and jaw pain |
| PAH meds which is CI if Pt on nitrates | PD5, Biociguat |
| ERA (Endothelin receptor antagonists) (MBA) | - Macitentan - Bosentan - Ambrisentan MoA: stimulates endothelin receptors |
| Prostacyclins (T I E) | - Treprostinil - lloprost - Epoprostenol |
| warnings associated with tadalafil (Adcirca) | PDE-5 have a warning for NAION (nonarteritic anterior ischemic optic, neuropathy) - Hearing loss - Vision loss - Priapism - Hypotension PDE-5 MoA: increases cGMP levels |
| treprostinil administration | Subcutaneous treprostinil is associated with pain at both old and current administration sites in a majority of patients. |
| Box warning Bosentan (Tracleer) | hepatotoxicity and/or increased liver function tests for all ERAs |
| ERA Boxed warnings | - Restricted access programs: embryo-fetal toxicity |
| epoprostenol (Veletri) | The medication is continued without interruptions. |
| Which PAH medications require a negative pregnancy test before starting and monthly thereafter? | All of the endothelin receptor antagonists (ERAs) and riociguat have REMS programs due to the boxed warnings for teratogenicity. |